Issued Patents 2023
Showing 1–4 of 4 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11666579 | Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione | Maria Soraya Carrancio Anton, Tonia J. Buchholz, Shailaja Kasibhatla, Antonia Lopez-Girona, Rama Krishna Narla | 2023-06-06 |
| 11628172 | Methods of treating chronic lymphocytic leukemia using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione | Preethi Janardhanan, Shailaja Kasibhatla, Antonia Lopez-Girona | 2023-04-18 |
| 11590117 | Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide | Soraya Carrancio, Paul Hollenbach, Antonia Lopez-Girona, Kyle MacBeth, Irit Rappley +1 more | 2023-02-28 |
| 11583536 | Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use | Maria Soraya Carrancio Anton, Tonia J. Buchholz, Henry Chang, Ellen Filvaroff, Shailaja Kasibhatla +5 more | 2023-02-21 |